IDH2 GENE MUTATION
Clinical trials for IDH2 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new IDH2 GENE MUTATION trials appear
Sign up with your email to follow new studies for IDH2 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo targets genetic driver in High-Risk blood disorders
Disease control Recruiting nowThis study is testing whether a drug called enasidenib, sometimes combined with another drug called azacitidine, can help control high-risk myelodysplastic syndrome (MDS) in patients who have a specific genetic mutation called IDH2. The trial includes 63 patients who either haven…
Matched conditions: IDH2 GENE MUTATION
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New drug combo aims to tame aggressive leukemia
Disease control Recruiting nowThis study is testing whether two drugs, enasidenib and azacitidine, work better together to control a specific type of acute myeloid leukemia (AML) that has come back or hasn't responded to other treatments. It is for patients whose cancer has a particular genetic change called …
Matched conditions: IDH2 GENE MUTATION
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC